News

Results of the 2009 International Society of Refractive Surgery survey examining refractive surgery practice patterns in the United States show total surgical volume decreased while surgeons are continuing to embrace new techniques and technologies that can afford safer, more predictable outcomes.

Senior ophthalmologists with years of surgical experience have performed thousands of cataract surgeries and often know what they want from an ophthalmic viscosurgical device.

An excimer laser offers a number of features that collectively contribute to outstanding outcomes when using this platform to perform LASIK for a range of refractive errors.

Results from 3 years of follow-up in the phase II clinical trial investigating an angle-supported phakic IOL for the treatment of moderate to high myopia indicate this anterior chamber implant provides excellent visual acuity and is associated with accurate predictability of refraction and promising safety.

A neuroprotective approach to the treatment of glaucoma is not imminent, but several promising approaches are under investigation.

The safety and efficacy of cataract removal using torsional ultrasound with a proprietary handpiece and phacoemulsification system have been raised to a higher level by a recent software upgrade, according to one expert.

An intraocular device is a new concept in the treatment of age-related macular degeneration that taps into telescopic mirror technology to redesign patients' vision, according to experts.

Ranibizumab for the treatment of macular edema associated with central retinal vein occlusion demonstrated rapid and sustained improvement as early as 7 days after the start of treatment through 6-month interim analysis.

As Congress continues to debate health-care reform and how best to pay physicians for providing medical care to the nation's neediest and elderly people, ophthalmologists are increasingly frustrated by the instability it wreaks upon their practices.

Individuals who are visually impaired are more likely to be in a lower socioeconomic bracket in the United States, not to have private insurance, and to have an eye disease that is undetected.

The new Boston Convention and Exhibition Center will house the 2010 annual meetings of the American Society of Cataract and Refractive Surgery, the American Society of Ophthalmic Administrators Congress on ophthalmic practice management, and a program for technicians and nurses, April 9-14.

As everyone knows, the key roles played by vice presidents are to go to funerals and to say things that serve as fodder for comedians.

There is no shortage of studies to measure the costs of visual impairment, but because the studies use a variety of approaches to analyze data, it has been difficult to draw conclusions.

A proprietary surgical microscope allows dynamic control of the red reflex to provide unsurpassed intraocular visualization and to improve the ease and safety of cataract surgery.

The public has until March 5 to submit comments related to presentations made at a Feb. 18 public hearing at which FDA officials discussed challenges related to the premarket notification, or 510(k) process, used to review and clear certain medical devices marketed in the United States.

Lux Biosciences Inc. has submitted simultaneous regulatory filings to the FDA and the European Medicines Agency seeking marketing approval for an investigational drug, oral voclosporin (LUVENIQ or LX211), for the treatment of noninfectious uveitis involving the intermediate or posterior segments of the eye.

The Japanese Ministry of Health, Labor and Welfare has given regulatory approval for STAAR Surgical Co. to market its implantable contact lens (Visian Implantable Collamer Lens) in that country for the treatment of myopia.